Lloyd-Jones D, Tokarewicz A, Watson P G
Br J Ophthalmol. 1981 Sep;65(9):641-3. doi: 10.1136/bjo.65.9.641.
Thirty-nine patients took part in a double-blind, between-patient clinical trial to compare clobetasone butyrate, betamethasone phosphate, and placebo eye drops in the treatment of episcleritis. Although from the symptom scores the patients given placebo appeared to do as well as the other patients in the first week of treatment, they did significantly less well after this time. Clobetasone butyrate and betamethasone phosphate eye drops seemed to be equally effective in the treatment of this disease.
39名患者参与了一项双盲、患者间的临床试验，以比较丁酸氯倍他松、磷酸倍他米松和安慰剂眼药水治疗巩膜炎的效果。尽管从症状评分来看，接受安慰剂治疗的患者在治疗第一周的表现似乎与其他患者一样好，但在此之后他们的表现明显较差。丁酸氯倍他松和磷酸倍他米松眼药水在治疗这种疾病方面似乎同样有效。
